Current Research Trials

Clinic based

---

LSR ACUITY: Longitudinal surveillance registry of ACUITY spiral lead

PEGASUS TIMI 54: A study to determine if a ticagrelor decreases the frequency of cardiovascular events in patients with prior heart attack.

PRE-DETERMINE: A study of patients with a history of coronary artery disease to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality. 

REVEAL TIMI 55: The REVEAL trial aims to determine whether lipid modification with anacetrapib 100mg daily reduces the risk of coronary death, myocardial infarction (MI) or coronary revascularization in patients with circulatory problems who have their Low-density Lipoprotein (LDL) cholesterol level treated with a statin.

Hospital based

---

CHOICE: Carotid stenting for high surgical-risk patients.

CREATE PAS: Carotid revascularization with ev3 arterial technology evolution post approval study. 

DAL-ACUTE: A study of dalcetrapib in patients hospitalized for an acute coronary syndrome (Dal-ACUTE).

GORE FREEDOM: The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System when used for embolic protection during carotid artery stenting.

PHOENIX: A clinical trial comparing cangrelor to clopidogrel standard therapy in subjects who require percutaneous coronary intervention (PCI)

TAXUS Liberte: A post approval study designed to collect real-world safety and clinical outcomes in patients receiving one or more TAXUS Liberte stents and prasugrel as part of the dual antiplatelet therapy drug regiment.

VISTA 16: A study to evaluate the safety and efficacy of varespladib on morbidity and mortality when added to atorvastatin and standard of care in subjects with acute coronary syndrome.